Expression of recombinant human coagulation factor VII by the lizard Leishmania expression system

22Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The variety of recombinant protein expression systems have been developed as a resource of FVII gene expression. In the current study, the authors used a novel protein expression system based on the Iranian Lizard Leishmania, a trypanosomatid protozoan as a host for expression of FVII. Plasmid containing cDNA encoding full-length human FVII was introduced into Lizard Leishmania and positive transfectants were analyzed by SDS-PAGE and Western blot analysis. Furthermore, biological activity of purified protein was detected by PT assay. The recombinant strain harboring a construct was analyzed for expression of FVII at the mRNA and protein level. Purified rFVII was obtained and in order to confirm the purified compound was in fact rFVII. Western blot analysis was carried out. Clotting time in PT assay was reduced about 30 seconds with the purified rFVII. In Conclusion, this study has demonstrated, for the first time, that Leishmania cells can be used as an expression system for producing recombinant FVII. Copyright © 2011 Sina Mirzaahmadi et al.

Cite

CITATION STYLE

APA

Mirzaahmadi, S., Asaadi-Tehrani, G., Bandehpour, M., Davoudi, N., Tahmasbi, L., Hosseinzadeh, N., … Kazemi, B. (2011). Expression of recombinant human coagulation factor VII by the lizard Leishmania expression system. Journal of Biomedicine and Biotechnology, 2011. https://doi.org/10.1155/2011/873874

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free